Publikationen (42) Publikationen, an denen Forscher/innen teilgenommen haben

2009

  1. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms

    PLoS ONE, Vol. 4, Núm. 9

  2. Adipose-derived cardiomyogenic cells: In vitro expansion and functional improvement in a mouse model of myocardial infarction

    Cardiovascular Research, Vol. 83, Núm. 4, pp. 757-767

  3. Advances in interleukin-12 gene therapy for acquired liver diseases

    Current Gene Therapy, Vol. 9, Núm. 2, pp. 62-71

  4. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of Pemphigus vulgaris

    Experimental Dermatology, Vol. 18, Núm. 9, pp. 771-780

  5. Clinical development of combination strategies in immunotherapy: Are we ready for more than one investigational product in an early clinical trial?

    Immunotherapy, Vol. 1, Núm. 5, pp. 845-853

  6. Coagulación 2009: una visión moderna de la hemostasia

    Revista de medicina, Vol. 53, Núm. 1, pp. 19-23

  7. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

    Cancer, Vol. 115, Núm. 22, pp. 5210-5217

  8. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy

    Transfusion, Vol. 49, Núm. 9, pp. 1901-1910

  9. Cáncer y tromboembolia venosa: una antigua asociación con nuevos escenarios

    Medicina Clinica, Vol. 133, Núm. 14, pp. 545-546

  10. Diferencias de sexo y enfermedad arterial coronaria

    Clínica e investigación en arteriosclerosis, Vol. 21, Núm. 4, pp. 190-192

  11. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders

    Human Gene Therapy, Vol. 20, Núm. 8, pp. 908-917

  12. Enfermedad tromboembólica venosa: una llamada urgente a la acción

    Medicina Clinica, Vol. 133, Núm. 14, pp. 547-551

  13. Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia

    European Journal of Cancer, Vol. 45, Núm. 10, pp. 1877-1889

  14. Epigenetic regulation of MicroRNAs in acute lymphoblastic leukemia

    Journal of Clinical Oncology, Vol. 27, Núm. 8, pp. 1316-1322

  15. Epigenetic regulation of microRNA expression in colorectal cancer

    International Journal of Cancer, Vol. 125, Núm. 11, pp. 2737-2743

  16. Epigenetic signatures associated with different levels of differentiation potential in human stem cells

    PLoS ONE, Vol. 4, Núm. 11

  17. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

    Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453

  18. Expansion of CD8+CD57+ T cells in an immunocompetent patient with acute toxoplasmosis

    Advances in Hematology, Vol. 2009

  19. Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications

    PLoS ONE, Vol. 4, Núm. 12

  20. Factores ligados a angiogénesis, coagulación y fibrinólisis en el pronóstico de pacientes con cáncer colorectal

    Salud(i)Ciencia, Vol. 16, Núm. 8, pp. 848-854